PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Tonix Pharmaceuticals Holding Corp.
Filed: December 10, 2021
Period of Report: December 10, 2021
Accession Number: 0001839882-21-018767

View Document ↗ View on SEC.gov ↗